Immunoassay Instruments Market to be Driven by Growing Preference for Personalized Medicine

Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platforms. Currently, market players are engaged in developing immunoassay platforms with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances introduced to researchers include shorter turnaround times (TAT), higher productivity and easy operation thereby ensuring efficient detection and determination with accurate results. The market is witnessing significant advances in the design of immunoassay platforms shifting from conventional non-competitive assays to competitive assays that are permitting the efficient detection of small molecules such as drug pollutants and metabolites. For instance, introduction of ADVIA Centaur CP Immunoassay System by Siemens Healthcare, a mid-sized immunoassay system that provides a broad menu of tests and enhanced workflow which enables overall cost reduction and eliminate the need for multiple systems.

Get Report Sample @

The growing prevalence of chronic diseases is the main factor driving the global immunoassay instruments market. In addition, the increasing rate of HIV infections, growing preference for personalized medicine, and technological advancements in immunoassay instruments are propelling the global market. However, the high costs linked with technical advancements is the restraining factor acting upon the global immunoassay instruments market.

By type, the global market for immunoassay instruments has been segmented into radioimmunoassay analyzers, multiplexed assay systems, enzyme immunoassay instruments, chemiluminescence analyzers, immuno fluorescence analyzers, and enzyme-linked fluorescent systems. In 2013, the chemiluminescence analyzers segment held a share of 27% in the overall market owing to the high accuracy and sensitivity displayed by chemiluminescence analyzers in detection of analytes. This segment is estimated to remain dominant throughout the forecast period. On the other hand, the enzyme-linked fluorescent systems and immuno fluorescence analyzers segments are also expected to witness significant growth in the next few years. By application, the global market for immunoassay instruments has been classified into oncology, drugs of abuse, endocrinology, autoimmune diseases, therapeutic drug monitoring, infectious diseases, and cardiology.

View Report @

Leave a Reply